Global Cell Therapy Pipeline Analysis

56 views

Published on

“Global Cell Therapy Pipeline Analysis” report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the Cell Therapy based drug development process.

For Report Sample Contact: rajesh@pnspharma.com

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
56
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Global Cell Therapy Pipeline Analysis

  1. 1. Global Cell Therapy Pipeline Analysis “Global Cell Therapy Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed for the treatment of multiple disease based upon Cell Therapy. Research report covers all the ongoing drug development in various development phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight for each drug profile in development phase enables the reader to identify and understand the Cell Therapy associated with the various diseases. This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the Cell Therapy based drug development process. For Report Sample Contact: rajesh@pnspharma.com Following parameters for each drug profile in development phase are covered in “Global Cell Therapy Pipeline Analysis” research report: • Drug Profile Overview • Alternate Names for Drug • Active Indication • Phase of Development • Mechanism of Action • Brand Name • Orphan Designation by Indication, Country & Organisation • Country for Clinical Trial • Owner / Originator/ Licensee/Collaborator • Administrative Route • Drug Class • ATC Codes
  2. 2. Breakup of Cell Therapies by Development Phase: • Research: 19 • Preclinical: 80 • Phase-I: 30 • Phase-I/II: 28 • Phase-II: 34 • Phase-II/III: 2 • Phase-III: 15 • Registered: 4 • Marketed: 9 For Report Sample Contact: rajesh@pnspharma.com Each Drug Profile has Tables Representing Following Information: • Alternate Names • Originator & Owner • Collaborator • Technology Provider • Licensee • Highest Development Phase • Indications • Class • Mechanism of Action • ATC Code • Designated Brand Name

×